GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vista Pharmaceuticals Ltd (BOM:524711) » Definitions » Cyclically Adjusted Book per Share

Vista Pharmaceuticals (BOM:524711) Cyclically Adjusted Book per Share : ₹10.22 (As of Mar. 2025)


View and export this data going back to 1994. Start your Free Trial

What is Vista Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Vista Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2025 was ₹7.380. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹10.22 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Vista Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 1.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Vista Pharmaceuticals was 3.90% per year. The lowest was 3.50% per year. And the median was 3.70% per year.

As of today (2025-07-19), Vista Pharmaceuticals's current stock price is ₹11.25. Vista Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹10.22. Vista Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 1.10.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vista Pharmaceuticals was 1.86. The lowest was 0.74. And the median was 1.09.


Vista Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Vista Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vista Pharmaceuticals Cyclically Adjusted Book per Share Chart

Vista Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.96 9.23 9.75 10.04 10.22

Vista Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.04 - 10.24 - 10.22

Competitive Comparison of Vista Pharmaceuticals's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vista Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vista Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vista Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vista Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Vista Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vista Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=7.38/157.5517*157.5517
=7.380

Current CPI (Mar. 2025) = 157.5517.

Vista Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 99.841 0.000
201509 3.496 101.753 5.413
201512 2.723 102.901 4.169
201603 4.633 102.518 7.120
201606 0.000 105.961 0.000
201609 4.443 105.961 6.606
201612 4.604 105.196 6.895
201703 6.251 105.196 9.362
201706 0.000 107.109 0.000
201709 8.443 109.021 12.201
201712 0.000 109.404 0.000
201803 10.930 109.786 15.685
201806 0.000 111.317 0.000
201809 10.998 115.142 15.049
201812 0.000 115.142 0.000
201903 11.790 118.202 15.715
201906 0.000 120.880 0.000
201909 11.037 123.175 14.117
201912 0.000 126.235 0.000
202003 9.762 124.705 12.333
202006 0.000 127.000 0.000
202009 10.207 130.118 12.359
202012 9.688 130.889 11.661
202103 8.927 131.771 10.674
202106 0.000 134.084 0.000
202109 9.363 135.847 10.859
202112 0.000 138.161 0.000
202203 9.636 138.822 10.936
202206 0.000 142.347 0.000
202209 9.367 144.661 10.202
202212 0.000 145.763 0.000
202303 9.774 146.865 10.485
202306 0.000 150.280 0.000
202309 8.730 151.492 9.079
202312 0.000 152.924 0.000
202403 8.628 153.035 8.883
202406 0.000 155.789 0.000
202409 7.835 157.882 7.819
202412 0.000 158.323 0.000
202503 7.380 157.552 7.380

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Vista Pharmaceuticals  (BOM:524711) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vista Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=11.25/10.22
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vista Pharmaceuticals was 1.86. The lowest was 0.74. And the median was 1.09.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Vista Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Vista Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vista Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 104, Kakateeya Hills, Ravindra Co Operative Society, Guttala Begumpet, Hyderabad, TG, IND, 500033
Vista Pharmaceuticals Ltd is an Indian-based company engaged in single operating segment which is the manufacturing of Pharmaceutical products. The company offers over-the-counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, and Indomethacin are the drugs offered by the company in a capsule dosage form. The company generates all of its operating revenue from sales within India.

Vista Pharmaceuticals Headlines

No Headlines